ENO2 and brain injury: For instance, S100B, neuron-specific enolase (NSE), and some other neurospecific analytes are widely used in clinical practice as serum biomarkers of traumatic brain injury; they help to predict severity of injury and intracranial disease burden, and to assess brain damage and clinical outcome [10,11,12].